Regeneron Pharmaceuticals (NASDAQ: REGN) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA